Mark your calendar—May 2nd is a day to shop for a cause! We’re thrilled to announce that AIM at Melanoma…

By Mara Klecker Page Weinstein has a special request for photographers who take her portraits: Don’t edit out the scar…

Introduction Immunotherapy drugs like ipilimumab (Yervoy), nivolumab (Opdivo), pembrolizumab (Keytruda), and others are powerful tools to combat melanoma. Indeed, recent…

A Q&A with an Investigator at the National Institutes of Health Dr. Michael Sargen M.D. is an Assistant Clinical Investigator…

This month, we delve into one of the most groundbreaking developments in melanoma research: vaccines. Our spotlight article examines the potential of mRNA…

Introduction Scientists have recently advanced a strategy to send human cells instructions to generate an immune response against cancer. It…

In this episode, we dive into the transformative power of art therapy in cancer care. Art therapy goes beyond traditional…

Side Effect Central is a new series of articles designed to help patients with melanoma and their caregivers understand the…

Most people are aware of the link between indoor tanning and skin cancer – so why do they still do…

AIM at Melanoma is pleased to announce that we’ve partnered with WearSPF, a suncare line with multiple mineral and chemical…